Boråsföretaget Ladulaas Kliniska Studier (Ladulaas AB) har fått internationell uppmärksamhet för arbetet med Kliniska Studier
"Vi är väldigt stolta och glada över denna utmärkelse som vi ser som ett erkännande för våra ansträngningar att förbättra hälsan samt bidra till att öka behandlingsalternativen för personer med oftast kroniska sjukdomar. Vårt arbete leder till ny kunskap om existerande och nya läkemedel samt behandlingsmetoder som kommer samhället tillgodo och bidrar till en förbättrad hälsa."
säger Katarina Berndtsson Blom, VD och Klinikchef för Ladulaas Kliniska Studier.
För mer information kontakta:
Katarina Berndtsson Blom tel 033-131331 eller 0730-391166.
Ladulaas Kliniska Studier (Ladulaas AB) är ett svenskt företag som arbetar med kliniska studier sedan 2007. Företaget startade sin verksamhet i Skene men är nu verksamt i Borås sedan 2014. Ladulaas Kliniska Studier arbetar på uppdrag från de forskande läkemedelsföretagen, företag som utvecklar medicinska uppfinningar och företag som utvecklar livsmedel med hälsoeffekter. Sedan start är fler än 80 studier genomförda. I dagsläget är 12 studier pågående och tre under uppstart. En klinisk studie kan pågå från 16 veckor upp till 10 år.
GHP Recognises Ladulaas Clinical Trials in the Healthcare & Pharmaceutical Awards 2018
United Kingdom, 2018 – GHP has awarded Ladulaas Clinical Trials, Clinical Trials Experts of the Year 2018 - Nordic Region in the Healthcare & Pharmaceutical Awards 2018.
Now in its third year, the Healthcare & Pharmaceutical Awards returns to celebrate the contributions made by organisations and individuals operating within the world’s most vital industries.
It is our desire to reward those who demonstrate dedication to furthering the advancements within healthcare and pharmaceutical services and products. For this reason, we have developed a merit-based judging process providing entrants with the opportunity to share their proudest moments, and greatest achievements within the healing arts.
Ladulaas Clinical Trials offers drug tests as well as studies of medical inventions and food with health effects. As part of its quest for excellence, Ladulaas has had four audits from pharmaceutical companies and one inspection from Läkemedelsverket (the Medical Products Agency), all of whom have given the clinic high ratings. This offers clients and participants alike the peace of mind of knowing that they are in safe hands when they work with this dynamic and innovative clinic.
Discussing the success of their winners, Katherine Benton, Awards Coordinator commented: “It has been a true pleasure to showcase the exceptional dedication that each and every one of my deserving winners has shown over the past 12 months. Clinical trials are an important aspect of the healthcare and pharmaceutical space, and as such it is with great pleasure that I recognise this unique and dedicated firm. Furthermore, it is my pleasure to offer Ladulaas Clinical Trials my congratulations and wish them the very best of luck for the future.”
GHP prides itself on the validity of its awards and winners. The awards are given solely on merit and are awarded to commend those most deserving for their ingenuity and hard work, distinguishing them from their competitors and proving them worthy of recognition.
To learn more about our award winners and to gain insight into the working practices of the “best of the best” in the health and pharma industries, please visit our website (http://www.ghp-news.com/) where you can access the winners supplement.
ENDS
NOTES TO EDITORS
About GHP
GHP is a quarterly magazine brought to you by AI Global Media Ltd, a publishing house that has reinvigorated corporate finance news and reporting. Its topical news articles make it a valued read, and this readability ensures that advertisers will benefit greatly from their investment.
Established to enhance communication networks & collaboration across all themes and disciplines within 3 main categories; Human, Animal & Environmental Health.
About Ladulaas Clinical Trials
Since its inception in 2007, Ladulaas has flourished, and over the past 11 years the firm has undertaken almost 80 trials during this time. As a privately owned independent clinic conducting trials for big international pharma and med-tech companies, prestigious universities, and CROs, from around the world, Ladulaas has achieved a great deal since it first began. To find out more, please visit their website: www.ladulaaskliniken.se